Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

Presentation SIF 2019

Next Generation TAVR Devices

Presenter: Michael J Reardon

March 30, 2019

Presentation SIF 2019

Top 4 Structural Trials of the Last Year

Presenter: Michael J Reardon

March 27, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

Partner Content

Building Your TAVR Program - Medtronic

October 31, 2019

Partner Content

The Foundations of TAVR - Medtronic

October 29, 2019

CME

Low-Risk Patients: The Changing Face of TAVR

CME

Updates on TAVR in Low-Risk Patients

CME

Advertisement

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Illustrative Cases

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Next Generation TAVR Devices

Top 4 Structural Trials of the Last Year

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Primary Results From the Evolut Low Risk Trial

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Building Your TAVR Program - Medtronic

The Foundations of TAVR - Medtronic

Low-Risk Patients: The Changing Face of TAVR

Updates on TAVR in Low-Risk Patients

The Treatment of Mitral Regurgitation in 2019 and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content